$CME

CME Posts Record Q3 Revenue As Crypto Derivatives Push Continues

CME Group reported record Q3 revenue of $1.74B, up 13% YoY, with average daily volume at 29.4M contracts. Market-data revenue reached $243M. The company expanded its crypto offerings, announcing Bitcoin Cash and Uniswap futures, but did not disclose crypto-specific revenue. According to CME, first-half crypto derivatives volume averaged 279,800 contracts, with $8.3B in notional value.

Original reporting
Published Oct 23, 2026, 10:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 11:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CME Posts Record Q3 Revenue As Crypto Derivatives Push Continues — source image
Decision brief

The 30-second read

$CMEBullishMed
01

Why it matters

The earnings beat underscores CME's diversified revenue base and may attract investors seeking exposure to both traditional and digital asset markets.

02

Market read

CME's strong earnings could influence trading strategies in the broader exchange sector and crypto‑derivatives space.

03

What to watch

Regulatory scrutiny on crypto derivatives could limit future growth despite the revenue record.

Relevance 8/10Novelty 8/10Timing: post‑earnings release

Background

CME Group disclosed its Q3 2026 earnings, highlighting record revenue and expanding crypto‑derivatives activity.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME reported record Q3 revenue of $1.74 billion, a 13% year‑over‑year increase.

Expected impact

potential upside as investors price in strong revenue growth

Evidence & confidence

The large, unexpected revenue increase suggests better profitability and may lift the stock.

Market effects

Boosts outlook for exchange and derivatives operators, especially those with crypto exposure.

U.S. equity markets may see modest lift from the earnings surprise.

Signals growing importance of regulated crypto‑derivatives worldwide.

Counterpoint

Revenue growth may be offset by the opaque contribution of crypto products and potential regulatory headwinds.

Key entities

  • CME Group

    U.S.-listed exchange operator with expanding crypto‑derivatives offerings.

Related articles

$CMEMedAI 9/10

Key facts: CME Q3 Up; Adds BCH & UNI Futures; Crypto Revenue Embedded

CME Group (CME) reported Q3 2026 revenue of $1.74B (+13%), net income of $1.04B, and diluted EPS of $2.89 (+16%). The company launched Bitcoin Cash and Uniswap futures on Oct 19, 2026, and noted record average daily volume. Crypto revenue is embedded within broader market activities. CME also highlighted regional copper pricing divergences and 24/7 crypto trading volumes.

$CMEMed

CME Maintained by Barclays -- Price Target Raised to $321

Barclays maintained an Equal-Weight rating on CME Group (CME) but raised its price target to $321 from $281. CME's stock is currently priced at $305.65, which is 10.8% overvalued according to its GF Value™ of $275.98. The company has a GF Score™ of 88/100, indicating strong performance in profitability and growth. 19 gurus hold CME, with 12 adding to their positions recently.

$CMEMed

CME Maintained by Wells Fargo -- Price Target Raised to $333

Wells Fargo maintained an Overweight rating for CME Group and raised its price target to $333 from $315. CME operates the world's largest derivatives marketplace. GuruFocus values CME at $275.98, indicating a 10.9% overvaluation at its current price of $306.07. The company has a GF Score of 88, with strong growth and profitability metrics.